Rabkozol 20 contains Rabeprazole 20 mg, a proton pump inhibitor (PPI) that works by reducing the production of excess gastric acid. It is used for the management of various acid-related gastrointestinal conditions and associated symptoms.
Rabeprazole may be prescribed for acidity, heartburn, gastroesophageal reflux disease (GERD), gastritis, and certain peptic ulcer-related conditions, depending on the patient's clinical requirements and healthcare professional's assessment.
Each enteric-coated tablet contains Rabeprazole 20 mg and is manufactured under quality-controlled conditions under the KureKraft brand.